Terms: = Uterine cancer AND PRDM1, BLIMP1, 639, ENSG00000057657, MGC118925, PRDI-BF1, MGC118924, MGC118922, RP1-134E15_1, O75626, MGC118923 AND Prognosis
3578 results:
1. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
Tian Q; Huang J; Zhang Q; Zhao J
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract] [Full Text] [Related]
3. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
4. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
5. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
6. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
Zhang Y; Li L; Han Q; Wen L
J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
[TBL] [Abstract] [Full Text] [Related]
7. Risk assessment of extra-uterine involvement and prognosis in young type I endometrial carcinoma with high or moderate differentiation and less than 1/2 myometrial invasion.
Sun Y; Han P; Wang Y; Cheng X; Wu W; Liu Q; Ren F
Aging (Albany NY); 2024 Apr; 16(7):6445-6454. PubMed ID: 38575312
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics of patients with late recurrence endometrial cancer.
Çakır İ; Gülseren V; Özdemir İA; Abacı H; Talu ECK; Çakır ZE; Ata C; Kuru O; Gökçü M; Sancı M; Güngördük K
J Cancer Res Ther; 2024 Jan; 20(1):232-237. PubMed ID: 38554326
[TBL] [Abstract] [Full Text] [Related]
9. A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
Guo X; Zhao E; Guan Z; Li W; Zhang J; Tian S; Yao Y
J Int Med Res; 2024 Mar; 52(3):3000605241233966. PubMed ID: 38553028
[TBL] [Abstract] [Full Text] [Related]
10. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract] [Full Text] [Related]
11. Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals
Zhong C; Guo YE; Yang Q; Song Y; Wang T; Cai B; Chen H; Du H; Wan J; Liu Y; Li Y; Wan X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):100. PubMed ID: 38538277
[TBL] [Abstract] [Full Text] [Related]
12. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
[TBL] [Abstract] [Full Text] [Related]
13. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
14. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
[TBL] [Abstract] [Full Text] [Related]
16. A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.
Sun Y; Zhang K; Wang T; Zhao S; Gao C; Xue F; Wang Y
Sci Rep; 2024 Mar; 14(1):6134. PubMed ID: 38480789
[TBL] [Abstract] [Full Text] [Related]
17. [Postoperative lymph node metastasis status and related factors in patients with early-stage, low-risk endometrial cancer assessed by the Mayo criteria].
Shi XW; Wang DF; Zhang GN; Zhang J
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):736-741. PubMed ID: 38462353
[No Abstract] [Full Text] [Related]
18. CD146
Yu Z; Zhang Q; Wei S; Zhang Y; Zhou T; Zhang Q; Shi R; Zinovkin D; Pranjol ZI; Zhang J; Wang H
Cell Commun Signal; 2024 Mar; 22(1):170. PubMed ID: 38459564
[TBL] [Abstract] [Full Text] [Related]
19. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
[TBL] [Abstract] [Full Text] [Related]
20. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
[Next]
